Bvf I Gp Llc - Net Worth and Insider Trading
Bvf I Gp Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bvf I Gp Llc owns 25 companies in total, including Five Prime Therapeutics Inc (FPRX) , Eledon Pharmaceuticals Inc (ELDN) , and XOMA Royalty Corp (XOMA) among others .
Click here to see the complete history of Bvf I Gp Llc’s form 4 insider trades.
Insider Ownership Summary of Bvf I Gp Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FPRX | Five Prime Therapeutics Inc | 2020-10-06 | 10 percent owner |
ELDN | Eledon Pharmaceuticals Inc | 2020-10-01 | other: See Explanation of Responses |
XOMA | XOMA Royalty Corp | 2020-03-13 | 10 percent owner |
2020-06-01 | other: See Explanation of Responses | ||
2021-06-16 | other: See Explanation of Responses | ||
2020-08-18 | other: See Explanation of Responses | ||
2020-06-18 | other: See Explanation of Responses | ||
2020-03-02 | 10 percent owner | ||
2020-03-13 | 10 percent owner | ||
2020-11-12 | other: See Explanation of Responses | ||
2021-01-22 | other: See Explanation of Responses | ||
2020-10-30 | other: See Explanation of Responses | ||
2020-12-18 | other: See Explanation of Responses | ||
2022-01-25 | other: See Explanation of Responses | ||
2021-04-22 | other: See Explanation of Responses | ||
2020-11-18 | 10 percent owner | ||
2021-12-31 | other: See Explanation of Responses | ||
2021-10-28 | other: See Explanation of Responses | ||
2022-04-05 | director & 10 percent owner | ||
2022-06-16 | other: See Explanation of Responses | ||
2022-07-11 | 10 percent owner | ||
2022-12-19 | other: See Explanation of Responses | ||
2023-02-03 | other: See Explanation of Responses | ||
2023-05-11 | 10 percent owner | ||
2023-11-02 | other: See Explanation of Responses |
Bvf I Gp Llc Trading Performance
Bvf I Gp Llc Ownership Network
Bvf I Gp Llc Owned Company Details
What does Five Prime Therapeutics Inc do?
Who are the key executives at Five Prime Therapeutics Inc?
Bvf I Gp Llc is the 10 percent owner of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Inc/il .
Five Prime Therapeutics Inc (FPRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Five Prime Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and director & Chief Executive Officer David-alexandre C Gros .
Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does XOMA Royalty Corp do?
Who are the key executives at XOMA Royalty Corp?
Bvf I Gp Llc is the 10 percent owner of XOMA Royalty Corp. Other key executives at XOMA Royalty Corp include Chief Financial Officer Thomas M. Burns , director & Interim CEO Owen Hughes , and Chief Investment Officer Bradley Sitko .
XOMA Royalty Corp (XOMA) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in XOMA Royalty Corp (XOMA). Other recent insider transactions involving XOMA Royalty Corp (XOMA) include a net sale of 18,381 shares made by Owen Hughes , a net purchase of 3,250 shares made by Bradley Sitko , and a net sale of 9,775 shares made by Thomas M. Burns .
In summary, during the past 3 months, insiders sold 31,656 shares of XOMA Royalty Corp (XOMA) in total and bought 0 shares, with a net sale of 31,656 shares. During the past 18 months, 31,656 shares of XOMA Royalty Corp (XOMA) were sold and 6,750 shares were bought by its insiders, resulting in a net sale of 24,906 shares.
XOMA Royalty Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Royalty Corp Insider Transactions
- Download to Excel(.xls)
What does Merus NV do?
Who are the key executives at Merus NV?
Bvf I Gp Llc is the other: See Explanation of Responses of Merus NV. Other key executives at Merus NV include Chief Accounting Officer Harry Shuman , EVP & General Counsel Peter B. Silverman , and director & President & CEO & PFO Sven Ante Lundberg .
Merus NV (MRUS) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Merus NV (MRUS). Other recent insider transactions involving Merus NV (MRUS) include a net sale of 20,815 shares made by Harry Shuman , and a net sale of 94,386 shares made by Peter B. Silverman .
In summary, during the past 3 months, insiders sold 0 shares of Merus NV (MRUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 115,201 shares of Merus NV (MRUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 115,201 shares.
Merus NV (MRUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merus NV Insider Transactions
- Download to Excel(.xls)
What does Kymera Therapeutics Inc do?
Who are the key executives at Kymera Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include Chief Medical Officer Jared Gollob , Chief Operating Officer Jeremy G Chadwick , and 10 percent owner Atlas Venture Fund X, L.p. .
Kymera Therapeutics Inc (KYMR) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .
In summary, during the past 3 months, insiders sold 13,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 13,500 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.
Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kymera Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does IDEAYA Biosciences Inc do?
Who are the key executives at IDEAYA Biosciences Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of IDEAYA Biosciences Inc. Other key executives at IDEAYA Biosciences Inc include SVP & Chief Scientific Officer Michael Anthony White , director & President and CEO Yujiro S Hata , and See Remarks Briseno Andres Ruiz .
IDEAYA Biosciences Inc (IDYA) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in IDEAYA Biosciences Inc (IDYA). Other recent insider transactions involving IDEAYA Biosciences Inc (IDYA) include a net sale of 38,470 shares made by Jason Throne , a net sale of 425,000 shares made by Yujiro S Hata , and a net sale of 10,000 shares made by Briseno Andres Ruiz .
In summary, during the past 3 months, insiders sold 0 shares of IDEAYA Biosciences Inc (IDYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 514,470 shares of IDEAYA Biosciences Inc (IDYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 514,470 shares.
IDEAYA Biosciences Inc (IDYA)'s detailed insider trading history can be found in Insider Trading Tracker table.
IDEAYA Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Bvf I Gp Llc is the 10 percent owner of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
- Download to Excel(.xls)
What does XOMA Royalty Corp do?
Who are the key executives at XOMA Royalty Corp?
Bvf I Gp Llc is the 10 percent owner of XOMA Royalty Corp. Other key executives at XOMA Royalty Corp include Chief Investment Officer Bradley Sitko , director & Interim CEO Owen Hughes , and 10 percent owner Bvf Ii Gp Llc .
XOMA Royalty Corp (XOMAO.PFD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XOMA Royalty Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Royalty Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XOMA Royalty Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Royalty Corp Insider Transactions
- Download to Excel(.xls)
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 343,500 shares made by Robert I Blum , a net sale of 205,949 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .
In summary, during the past 3 months, insiders sold 90,420 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 90,420 shares. During the past 18 months, 652,527 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 652,527 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
- Download to Excel(.xls)
What does Infinity Pharmaceuticals Inc do?
Who are the key executives at Infinity Pharmaceuticals Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .
Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,
In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.
Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Infinity Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does GlycoMimetics Inc do?
Who are the key executives at GlycoMimetics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .
GlycoMimetics Inc (GLYC) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 17,500 shares made by Brian M. Hahn .
In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,271,499 shares of GlycoMimetics Inc (GLYC) were sold and 387,903 shares were bought by its insiders, resulting in a net sale of 1,883,596 shares.
GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
GlycoMimetics Inc Insider Transactions
- Download to Excel(.xls)
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 0 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Financial Officer Robert E. Gagnon .
Verastem Inc (VSTM) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 668 shares made by Daniel Calkins , a net sale of 20,888 shares made by Robert E. Gagnon , and a net sale of 6,617 shares made by Dan Paterson .
In summary, during the past 3 months, insiders sold 2,695 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 2,695 shares. During the past 18 months, 33,122 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,122 shares.
Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Management Llc .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang ,
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 173,973 shares of Rain Oncology Inc (RAIN) were sold and 1,372,418 shares were bought by its insiders, resulting in a net purchase of 1,198,445 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Bvf I Gp Llc is the 10 percent owner of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include 10 percent owner Paradigm Biocapital Advisors Lp , director & Chief Technology Officer Cyrus Harmon , and director & President and CEO Sean Bohen .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 1,710,000 shares made by G. Walmsley Graham .
In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,223,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 2,977,142 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
- Download to Excel(.xls)
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , Acting Chief Business Officer Savill Corrine , and director & President and CEO Nadim Ahmed .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 102,471 shares made by Jennifer Michaelson , a net sale of 4,962 shares made by Jeffrey Trigilio , and a net sale of 120,000 shares made by Savill Corrine .
In summary, during the past 3 months, insiders sold 16,000 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 16,000 shares. During the past 18 months, 237,078 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 237,078 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Repare Therapeutics Inc do?
Who are the key executives at Repare Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , President and CEO Lloyd Mitchell Segal , and EVP & Chief Financial Officer Steve Forte .
Repare Therapeutics Inc (RPTX) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .
In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.
Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repare Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Bvf I Gp Llc is the director & 10 percent owner of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & 10 percent owner Biotechnology Value Fund L P , director & Chief Executive Officer Santos Da Silva Jorge , and Chief Scientific Officer Kristian Reich .
MoonLake Immunotherapeutics (MLTX) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 802,051 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .
In summary, during the past 3 months, insiders sold 2,171,000 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 2,171,000 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 802,051 shares were bought by its insiders, resulting in a net sale of 1,853,689 shares.
MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
- Download to Excel(.xls)
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and Chief Medical Officer Robert Young Kim .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net sale of 225,853 shares made by David Kirn , and a net sale of 540,000 shares made by Viking Global Investors Lp .
In summary, during the past 3 months, insiders sold 500 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 500 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 830,288 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ESSA Pharma Inc do?
Who are the key executives at ESSA Pharma Inc?
Bvf I Gp Llc is the 10 percent owner of ESSA Pharma Inc. Other key executives at ESSA Pharma Inc include 10 percent owner Biotech Growth N V , Chief Operating Officer Peter Virsik , and director & Chief Executive Officer David Ross Parkinson .
ESSA Pharma Inc (EPIX) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in ESSA Pharma Inc (EPIX). Other recent insider transactions involving ESSA Pharma Inc (EPIX) include a net sale of 81,945 shares made by Peter Virsik , a net purchase of 99,730 shares made by Franklin M Berger , and a net sale of 7,879,583 shares made by Biotech Growth N V .
In summary, during the past 3 months, insiders sold 7,883,053 shares of ESSA Pharma Inc (EPIX) in total and bought 0 shares, with a net sale of 7,883,053 shares. During the past 18 months, 7,961,528 shares of ESSA Pharma Inc (EPIX) were sold and 108,953 shares were bought by its insiders, resulting in a net sale of 7,852,575 shares.
ESSA Pharma Inc (EPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
ESSA Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Third Harmonic Bio Inc do?
Who are the key executives at Third Harmonic Bio Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Third Harmonic Bio Inc. Other key executives at Third Harmonic Bio Inc include Chief Medical Officer Edward R. Conner , other: See Explanation of Responses Biotechnology Value Fund L P , and Chief Administrative Officer Julie Person .
Third Harmonic Bio Inc (THRD) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Third Harmonic Bio Inc (THRD). Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 33,970 shares made by Julie Person , a net sale of 14,370 shares made by Edward R. Conner , and a net sale of 25,114 shares made by .
In summary, during the past 3 months, insiders sold 1,019,580 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 1,019,580 shares. During the past 18 months, 1,107,234 shares of Third Harmonic Bio Inc (THRD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,107,234 shares.
Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Third Harmonic Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Structure Therapeutics Inc do?
Who are the key executives at Structure Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Structure Therapeutics Inc. Other key executives at Structure Therapeutics Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and other: See Explanation of Responses Bvf Ii Gp Llc .
Structure Therapeutics Inc (GPCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Structure Therapeutics Inc (GPCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Structure Therapeutics Inc (GPCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Structure Therapeutics Inc (GPCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Structure Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Bvf I Gp Llc is the 10 percent owner of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and Chief Development Officer Shane Olwill .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 6,000 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does POINT Biopharma Global Inc do?
Who are the key executives at POINT Biopharma Global Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .
POINT Biopharma Global Inc (PNT) Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in POINT Biopharma Global Inc (PNT). Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P ,
In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,161,278 shares.
POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
POINT Biopharma Global Inc Insider Transactions
- Download to Excel(.xls)
Bvf I Gp Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Bvf I Gp Llc. You might contact Bvf I Gp Llc via mailing address: 44 Montgomery St., 40th Floor, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey